Invention Grant
- Patent Title: Combined therapeutical treatment of hyperproliferative diseases
- Patent Title (中): 联合治疗过度增生性疾病
-
Application No.: US10412684Application Date: 2003-04-14
-
Publication No.: US07884082B2Publication Date: 2011-02-08
- Inventor: Bruno Tocque
- Applicant: Bruno Tocque
- Applicant Address: FR Antony
- Assignee: Aventis Pharma SA
- Current Assignee: Aventis Pharma SA
- Current Assignee Address: FR Antony
- Agency: Wiley Rein LLP
- Priority: FR9500436 19950117
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N15/74
Abstract:
A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.
Public/Granted literature
- US20050209177A9 Combined therapeutical treatment of hyperproliferative diseases Public/Granted day:2005-09-22
Information query
